Global MRI Contrast Media Agents Market Growth 2022-2028

Global MRI Contrast Media Agents Market Growth 2022-2028

MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). MRI contrast media agents are widely used to identify the presence of tumors, aneurysms, and other abnormalities in the tissues.

The global market for MRI Contrast Media Agents is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC MRI Contrast Media Agents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States MRI Contrast Media Agents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe MRI Contrast Media Agents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China MRI Contrast Media Agents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key MRI Contrast Media Agents players cover GE Healthcare, Bayer AG, Guerbet GmbH, Bracco Imaging Spa and VitalQuan LLC, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global MRI Contrast Media Agents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global MRI Contrast Media Agents market, with both quantitative and qualitative data, to help readers understand how the MRI Contrast Media Agents market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Liter.

Market Segmentation:

The study segments the MRI Contrast Media Agents market and forecasts the market size by Type (Gadobutrol, Gadoterate Meglumine and Gadobenate Dimeglumine), by Application (Hospitals, Clinics and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type

Gadobutrol

Gadoterate Meglumine

Gadobenate Dimeglumine

Gadopentetate Dimeglumine

Gadoteridol

Gadodiamine

Others

Segmentation by application

Hospitals

Clinics

Others

Segmentation by region

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

Major companies covered

GE Healthcare

Bayer AG

Guerbet GmbH

Bracco Imaging Spa

VitalQuan LLC

Miltenyi Biotec

BeiLu Pharma

Hengrui Medicine

Chapter Introduction

Chapter 1: Scope of MRI Contrast Media Agents, Research Methodology, etc.

Chapter 2: Executive Summary, global MRI Contrast Media Agents market size (sales and revenue) and CAGR, MRI Contrast Media Agents market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.

Chapter 3: MRI Contrast Media Agents sales, revenue, average price, global market share, and industry ranking by company, 2017-2022

Chapter 4: Global MRI Contrast Media Agents sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.

Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.

Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace

Chapter 10: Manufacturing cost structure analysis

Chapter 11: Sales channel, distributors, and customers

Chapter 12: Global MRI Contrast Media Agents market size forecast by region, by country, by type, and application.

Chapter 13: Comprehensive company profiles of the leading players, including GE Healthcare, Bayer AG, Guerbet GmbH, Bracco Imaging Spa, VitalQuan LLC, Miltenyi Biotec, BeiLu Pharma and Hengrui Medicine, etc.

Chapter 14: Research Findings and Conclusion

Please note: The report will take approximately 2 business days to prepare and deliver.